Quest Diagnostics (NYSE: DGX) reported Q4 EPS of $4.48, $0.24 better than the analyst estimate of $4.24. Revenue for the quarter came in at $3 billion versus the consensus estimate of $2.93 billion.

Outlook for First Half of 2021

The company estimates its first half 2021 results as follows:

	Low		High
Net revenues	$4.85 billion		$5.15 billion
Net revenues increase	32.9%		41.1%
Reported diluted EPS	$5.07		6.07
Adjusted diluted EPS	$5.90		$6.90
Cash provided by operations	At least $800 million
Capital expenditures	Approximately $200 million

Note on Non-GAAP Financial Measures

For earnings history and earnings-related data on Quest Diagnostics (DGX) click here.